• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于抑菌药物与杀菌药物的关键问题。

Key issues concerning fungistatic versus fungicidal drugs.

作者信息

Graybill J R, Burgess D S, Hardin T C

机构信息

Department of Medicine, University of Texas Health Science Center at San Antonio 78284, USA.

出版信息

Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):42-50. doi: 10.1007/BF01575120.

DOI:10.1007/BF01575120
PMID:9063673
Abstract

Are there any fungicidal drugs available today? A critical issue in answering this question is that of definition. The simplest, most stringent definitions identify fungistatic drugs as those that inhibit growth, whereas fungicidal drugs kill fungal pathogens. The immunocompetent host is usually far better equipped to eliminate fungal pathogens than the immunosuppressed host. Therefore, it would be especially desirable to have a truly fungicidal drug, one that absolutely kills and fungi, as a treatment option for the immunosuppressed patient. The critical question would be whether a fungicidal drug can be delivered to the target site in a concentration high enough for a sufficient time to reduce the intralesional fungal counts to zero. By this simple definition, there are no fungicidal drugs available today. However, an accepted alternative definition is that often used by the bacteriologist: Fungicidal drugs are those that lead to a reduction of 99.9% of the initial inocula. Although this less restrictive in vitro standard is more easily met, it has serious limitations. Whether the 99.9% kill should be an acceptable standard remains uncertain. As an alternative, the minimum inhibitory concentration, though indicating static activity, has served well; perhaps it should be the only information reported for fungal susceptibility testing.

摘要

如今有抗真菌药物吗?回答这个问题的一个关键问题是定义问题。最简单、最严格的定义将抑菌药物定义为抑制生长的药物,而杀菌药物则杀死真菌病原体。免疫功能正常的宿主通常比免疫抑制宿主更有能力清除真菌病原体。因此,对于免疫抑制患者的治疗选择而言,特别需要一种真正的杀菌药物,即一种能绝对杀死真菌的药物。关键问题在于,一种杀菌药物能否以足够高的浓度在足够长的时间内输送到靶部位,从而将病灶内的真菌数量降至零。按照这个简单的定义,如今没有杀菌药物。然而,细菌学家常用的一种公认的替代定义是:杀菌药物是那些能使初始接种菌量减少99.9%的药物。尽管这个体外标准限制较少,更容易达到,但它有严重的局限性。99.9%的杀灭率是否应作为一个可接受的标准仍不确定。作为一种替代方法,最低抑菌浓度虽然表明的是抑菌活性,但一直很有用;也许它应该是真菌药敏试验报告的唯一信息。

相似文献

1
Key issues concerning fungistatic versus fungicidal drugs.关于抑菌药物与杀菌药物的关键问题。
Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):42-50. doi: 10.1007/BF01575120.
2
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
3
Susceptibility testing methods of antifungal agents.抗真菌药物的药敏试验方法。
Methods Mol Med. 2005;118:3-12. doi: 10.1385/1-59259-943-5:003.
4
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.针对酵母和霉菌的杀真菌活性测定:从杀菌测试中吸取的经验教训以及标准化的必要性。
Clin Microbiol Rev. 2004 Apr;17(2):268-80. doi: 10.1128/CMR.17.2.268-280.2004.
5
Fungicidal versus Fungistatic: what's in a word?杀真菌与抑菌:一字之差有何区别?
Expert Opin Pharmacother. 2008 Apr;9(6):927-35. doi: 10.1517/14656566.9.6.927.
6
Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.特比萘芬和伊曲康唑的杀菌与抑菌活性:体外比较
J Am Acad Dermatol. 1998 May;38(5 Pt 3):S37-41. doi: 10.1016/s0190-9622(98)70482-7.
7
Echinocandins: The Expanding Antifungal Armamentarium.棘白菌素类药物:不断扩展的抗真菌药物武器库。
Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S604-11. doi: 10.1093/cid/civ814.
8
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.伏立康唑、伊曲康唑和两性霉素B对机会性念珠菌和暗色真菌的体外杀真菌活性。
J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001.
9
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
10
The exciting future of antifungal therapy.抗真菌治疗的激动人心的未来。
Eur J Clin Microbiol Infect Dis. 2000 Dec;19(12):897-914. doi: 10.1007/s100960000395.

引用本文的文献

1
Deletion of core septin gene in results in fungicidal activity of caspofungin.核心septin基因的缺失导致卡泊芬净的杀真菌活性。
bioRxiv. 2025 Feb 25:2025.02.25.640155. doi: 10.1101/2025.02.25.640155.
2
Optical Nanomotion Detection to Rapidly Discriminate between Fungicidal and Fungistatic Effects of Antifungals on Single-Cell .光学纳米运动检测以快速区分抗真菌剂对单细胞的杀菌和抑菌作用
Antibiotics (Basel). 2024 Jul 29;13(8):712. doi: 10.3390/antibiotics13080712.
3
Should Empiric Anti-Fungals Be Administered Routinely for All Patients with Perforated Peptic Ulcers? A Critical Review of the Existing Literature.

本文引用的文献

1
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.可通过氟康唑有效治疗的急性艾滋病相关隐球菌性脑膜炎患者的识别:抗真菌药敏试验的作用
Clin Infect Dis. 1996 Feb;22(2):322-8. doi: 10.1093/clinids/22.2.322.
2
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Clin Infect Dis. 1995 Oct;21(4):994-6. doi: 10.1093/clinids/21.4.994.
3
Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?停止针对球孢子菌性脑膜炎的唑类治疗是否有安全的时候?
是否应对所有消化性溃疡穿孔患者常规使用经验性抗真菌药物?对现有文献的批判性综述。
Pathogens. 2024 Jun 28;13(7):547. doi: 10.3390/pathogens13070547.
4
Azoles activate type I and type II programmed cell death pathways in crop pathogenic fungi.唑类药物激活作物病原菌中的细胞凋亡 I 型和 II 型途径。
Nat Commun. 2024 May 31;15(1):4357. doi: 10.1038/s41467-024-48157-9.
5
Again and Again-Survival of in Urine Containing Antifungals.反复出现——在含有抗真菌药物的尿液中的生存情况。
Pharmaceutics. 2024 Apr 29;16(5):605. doi: 10.3390/pharmaceutics16050605.
6
Antifungal activity of eumelanin-inspired indoylenepheyleneethynylene against .受真黑素启发的吲哚并苯撑乙炔对……的抗真菌活性
Front Microbiol. 2024 Jan 16;14:1339303. doi: 10.3389/fmicb.2023.1339303. eCollection 2023.
7
Screening of Entomopathogenic Fungal Culture Extracts with Honeybee Nosemosis Inhibitory Activity.具有蜜蜂微孢子虫病抑制活性的昆虫病原真菌培养提取物筛选
Insects. 2023 Jun 9;14(6):538. doi: 10.3390/insects14060538.
8
Antifungal activity against Fusarium oxysporum of quinolizidines isolated from three controlled-growth Genisteae plants: structure-activity relationship implications.从三种受控生长的染料木属植物中分离出的喹嗪类化合物对尖孢镰刀菌的抗真菌活性:构效关系启示
Nat Prod Bioprospect. 2023 Mar 20;13(1):9. doi: 10.1007/s13659-023-00373-4.
9
Antimicrobial Performance of Innovative Functionalized Surfaces Based on Enamel Coatings: The Effect of Silver-Based Additives on the Antibacterial and Antifungal Activity.基于釉质涂层的创新功能表面的抗菌性能:银基添加剂对抗菌和抗真菌活性的影响。
Int J Mol Sci. 2023 Jan 25;24(3):2364. doi: 10.3390/ijms24032364.
10
Disruption of Iron Homeostasis and Mitochondrial Metabolism Are Promising Targets to Inhibit Candida auris.铁稳态和线粒体代谢的破坏是抑制耳念珠菌的有前途的靶点。
Microbiol Spectr. 2022 Apr 27;10(2):e0010022. doi: 10.1128/spectrum.00100-22. Epub 2022 Apr 12.
Ann Intern Med. 1996 Feb 1;124(3):305-10. doi: 10.7326/0003-4819-124-3-199602010-00004.
4
Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis.唑类药物耐药是艾滋病合并隐球菌性脑膜炎患者临床复发的一个原因。
Int J STD AIDS. 1995 Sep-Oct;6(5):353-5. doi: 10.1177/095646249500600510.
5
Use of amphotericin B with azole antifungal drugs: what are we doing?两性霉素B与唑类抗真菌药物联合使用:我们在做什么?
Antimicrob Agents Chemother. 1995 Sep;39(9):1907-12. doi: 10.1128/AAC.39.9.1907.
6
Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.粒细胞缺乏患者合并两性霉素B治疗、粒细胞输注及GM-CSF给药用于播散性镰刀菌感染。
Clin Infect Dis. 1993 Apr;16(4):528-30. doi: 10.1093/clind/16.4.528.
7
Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group.氟康唑治疗球孢子菌性脑膜炎。美国国立过敏与传染病研究所真菌病研究小组。
Ann Intern Med. 1993 Jul 1;119(1):28-35. doi: 10.7326/0003-4819-119-1-199307010-00005.
8
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.伊曲康唑预防获得性免疫缺陷综合征患者组织胞浆菌病复发的研究。
Ann Intern Med. 1993 Apr 15;118(8):610-6. doi: 10.7326/0003-4819-118-8-199304150-00006.
9
Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis.在新型隐球菌性脑膜炎小鼠模型中体外唑类药敏性与体内反应的相关性
J Infect Dis. 1993 Aug;168(2):508-10. doi: 10.1093/infdis/168.2.508.
10
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.复发性新型隐球菌性脑膜炎患者的系列新型隐球菌分离株对两性霉素B和氟康唑的敏感性
Antimicrob Agents Chemother. 1993 Jun;37(6):1383-6. doi: 10.1128/AAC.37.6.1383.